The M14TIL trial involved 168 patients with stage 3c to 4 melanoma that was too advanced to be treatable with surgery, most of whom (89%) had failed earlier treatment with PD-1 inhibitors like BMS ...

Regeneron and Sanofi’s PD-1 inhibitor Libtayo will be tested in tandem with a cancer vaccine developed by BioNTech in melanoma in people who have failed treatment with other checkpoint inhibitors.

Neoadjuvant pepinemab treatment shows potential to enhance immune response and improve survival in metastatic melanoma and head and neck cancer. Vaccinex, Inc. announced promising findings ...

Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.

Melanoma is a type of skin cancer. When it spreads to other places in your body, it's called metastatic, or advanced. If you have fair skin or you’ve spent lots of time in the sun, it’s a ...

New Delhi: A recent study published in The Lancet Oncology has found that monitoring DNA fragments released by dying tumor cells into the bloodstream could be a powerful tool for predicting cancer ...

However, after embracing her and planting a kiss on her cheek, the Pope had a five-word response that was followed by much amusement, according to the Mail. Article continues below Lesley said ...

There are so many film experiences to choose from on Netflix, let us help you narrow down your choices. By Jason Bailey Sign up for our Watching newsletter to get recommendations on the best films ...

Suffered upper-body injury while walking back to Salt Lake City hotel in mid-January.

The biggest stories of the day delivered to your inbox.